Cargando…
Emerging treatments for scleroderma/systemic sclerosis
Systemic sclerosis (SSc) is a connective tissue disease characterized by progressive fibrosis of the skin and internal organs and has significant clinical sequelae. Management of SSc cutaneous disease remains challenging and often is driven by extracutaneous manifestations. Methotrexate is the typic...
Autores principales: | Zhu, Jane L, Black, Samantha M, Chen, Henry W, Jacobe, Heidi T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty Opinions Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170563/ https://www.ncbi.nlm.nih.gov/pubmed/34131653 http://dx.doi.org/10.12703/r/10-43 |
Ejemplares similares
-
Systemic Sclerosis: Scleroderma
por: Denman, A. M.
Publicado: (1989) -
Vascular involvement in systemic sclerosis (scleroderma)
por: Pattanaik, Debendra, et al.
Publicado: (2011) -
Immunopathogenesis of Pediatric Localized Scleroderma
por: Torok, Kathryn S., et al.
Publicado: (2019) -
Systemic sclerosis (scleroderma): remaining challenges
por: Connolly, Mary Karin
Publicado: (2021) -
Hypertensive Emergency As Initial Presentation of Systemic Sclerosis Sine Scleroderma
por: Rayamajhi, Sumugdha, et al.
Publicado: (2023)